"Misją Centrum Onkologii Ziemi Lubelskiej im. św. Jana z Dukli jest: Profesjonalne świadczenie pełnoprofilowych usług medycznych na rzecz Pacjenta Onkologicznego."

During the past decade, Centrum Onkologii Ziemi Lubelskiej im. Sw. Jana z Dukli, Oddzial Hematologiczny conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centrum Onkologii Ziemi Lubelskiej im. Sw. Jana z Dukli, Oddzial Hematologiczny" #1 collaborator was "EMD Serono" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Centrum Onkologii Ziemi Lubelskiej im. Sw. Jana z Dukli, Oddzial Hematologiczny" are "Acute Myeloid Leukemia" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials), "Diffuse Large B-Cell Lymphoma" (1 trials), "Mantle Cell Lymphoma and Diffuse Large B Cell Lymphoma" (1 trials) and "Relapsed/Refractory B Cell Malignancies" (1 trials). Many other conditions were trialed in "Centrum Onkologii Ziemi Lubelskiej im. Sw. Jana z Dukli, Oddzial Hematologiczny" in a lesser frequency.

Most popular intervention types in "Centrum Onkologii Ziemi Lubelskiej im. Sw. Jana z Dukli, Oddzial Hematologiczny" are "Drug" (3 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Azacitidine" (2 trials), "Avelumab" (1 trials), "Bendamustine" (1 trials), "Gemcitabine" (1 trials) and "Magrolimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centrum Onkologii Ziemi Lubelskiej im. Sw. Jana z Dukli, Oddzial Hematologiczny" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Centrum Onkologii Ziemi Lubelskiej im. Sw. Jana z Dukli, Oddzial Hematologiczny". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Centrum Onkologii Ziemi Lubelskiej im. Sw. Jana z Dukli, Oddzial Hematologiczny, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Centrum Onkologii Ziemi Lubelskiej im. Sw. Jana z Dukli, Oddzial Hematologiczny, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".